GlobeNewswire

Medtronic and Foxconn Partner to Increase Ventilator Production

Share
  • Companies Aim to Produce 10,000 Puritan Bennett™ 560 Ventilators Together in the United States Over the Next Year
  • Partnership Established after Medtronic Announces Ventilator Open Source Initiative

DUBLIN and MOUNT PLEASANT, Wis., June 18, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) and Foxconn Industrial Internet, a business group within Foxconn Technology Group (Foxconn), announced today that Foxconn has successfully completed Medtronic’s regulatory and quality requirements necessary to begin manufacturing Medtronic Puritan Bennett™ 560 (PB560) ventilators for Medtronic in the United States. Medtronic and Foxconn are currently ramping up plans to produce 10,000 PB560 ventilators over the next year at Foxconn’s Wisconn Valley Science and Technology Park in Mount Pleasant, Wis. The ventilators will be marketed and sold by Medtronic.

“No single company can meet the current demands for ventilators that are critical in the fight against COVID-19. Joining together with Foxconn immediately increases our production capacity to meet the increased demand and creates a flexible manufacturing model for us,” said Vafa Jamali, senior vice president and president of the Respiratory, Gastrointestinal and Informatics business, which is part of the Minimally Invasive Therapies Group at Medtronic. “Together, we can increase ventilator supply and help more patients and clinicians than any one company can do alone.”

“Foxconn is grateful to all front-line professionals who tirelessly work to serve others and is proud to partner with Medtronic to address this global pandemic. Foxconn’s manufacturing capabilities can bring to market life-saving medical equipment during these challenging times,” said Foo-Ming Fu, CEO of Foxconn Industrial Internet Wisconsin. “Foxconn’s flexibility to quickly react to global markets makes opportunities with partners like this possible. In the last two months, we went from zero ventilator manufacturing capabilities to a tested, qualified ventilator manufacturing cell.”

The two companies connected after Medtronic publicly shared the design specifications for the PB560 through the Medtronic ventilator open source initiative, which launched earlier this year. This effort allows global participants to evaluate options for rapid ventilator manufacturing at scale to help doctors treat patients fighting COVID-19. To date, there have been more than 200,000 registrations for the design specifications at Medtronic.com/openventilator.

To respond to global demand, if needed, Medtronic and Foxconn can increase their production capability to more than double the current Foxconn ventilator commitment.

Introduced in 2010, the PB560 is sold in more than 35 countries around the world. It is a compact, lightweight, and portable ventilator that provides airway support for both adults and children. It can be used in clinical settings and at home and provides mobile respiratory support.

Ventilators play a critical role in the management of patients with severe respiratory illness, such as COVID-19, who require assistance because they cannot breathe effectively. Without ventilation support, some patients with severe respiratory disease might not survive. By placing a patient on a ventilator, the patient’s lungs are permitted to rest and recover while the ventilator performs the functions of supplying oxygen and simulating the actions of breathing.

About Foxconn
Established in 1974, Foxconn Technology Group (“Foxconn”) is a leading technological solution provider, that has leveraged its expertise in software and hardware to integrate its unique manufacturing systems with emerging technologies.

By capitalizing on its expertise in Cloud Computing, Mobile Devices, IoT, Big Data, AI, Smart Networks and Robotics/Automation, the Group has expanded capabilities in four key technologies – Data Tech, Analytics Tech, Platform Tech, and Operations Tech. The company has research centers and testing laboratories internationally and has received more than 83,500 patents worldwide. In addition to maximizing value-creation for customers, Foxconn is also dedicated to enhancing the concept of environmental sustainability in the manufacturing process and serving as a best-practices model for global enterprises.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to risks and uncertainties, including risks related to the impact of COVID-19 on our business, operations and production, as well as demand for our offerings, competitive factors, difficulties and delays inherent in the development, manufacturing, marketing and sale of medical products, government regulation and general economic conditions and other risks and uncertainties described in the Company’s periodic reports on file with the U.S. Securities and Exchange Commission including the most recent Annual Report on Form 10-K of the Company, as filed with the U.S. Securities and Exchange Commission. In some cases, you can identify these statements by forward-looking words, such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “looking ahead,” “may,” “plan,” “possible,” “potential,” “project,” “should,” “will,” and similar words or expressions, the negative or plural of such words or expressions and other comparable terminology. Actual results may differ materially from anticipated results. Medtronic does not undertake to update its forward-looking statements or any of the information contained in this press release, including to reflect future events or circumstances.

-end-


John Jordan
Medtronic plc
Public Relations
+1-508-452-4891

Ryan Weispfenning
Medtronic plc
Investor Relations
+1-763-505-4626

Robert Schlaeger
Foxconn
Public Relations
media@foxconn.com


About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Update: USD TENDER OPERATION ANNOUNCEMENT9.7.2020 13:30:00 CESTPress release

USD TENDER OPERATION ANNOUNCEMENT JUL 09, 2020 Transaction type: Reverse TransactionOperation type:Liquidity providingTender date:JUL-09-2020Time for submission of bids14.00-14.30 (CEST)Start date:JUL-13-2020Maturity date:OKT-05-2020Duration:84 daysOffered volume:10.0 bln Min bid amount: 100 mlnMaximum bid amount: 4.0 blnMax number of bids:10Lowest interest supplement:0.25 percentage pointsMin bid rate:0.32 %Allocation time:15.00 (CEST) on Tender date Approved counterparties are invited to submit bids to the Riksbank, tel +46 8 6966970 by 14.30 (CEST) pm on Jul 9, 2020. Confirmation of bids to e-mail: https://www.globenewswire.com/Tracker?data=n95w75utTQsLhotPy52ty3xzHF-mU33UtdobUjUHPHbKrTbsK46lD3x0a5wjeEH4dMz9S1Iu-bGG_xgH_VZ_qg== eol@riksbank.se

Mandalay Resources Corporation Announces Production and Sales Results for the Second Quarter of 20209.7.2020 13:00:10 CESTPress release

TORONTO, July 09, 2020 (GLOBE NEWSWIRE) -- Mandalay Resources Corporation ("Mandalay" or the "Company") (TSX: MND, OTCQB: MNDJF) announced today its production and sales results for the second quarter of 2020. In the second quarter of 2020, Mandalay produced a consolidated 24,752 saleable ounces of gold equivalent and sold 24,916 ounces of gold equivalent. Dominic Duffy, President and Chief Executive Officer of Mandalay, commented, “Both operations continued their strong start to the year with a quarter-over-quarter improvement in total ounces of gold equivalent sold. The second quarter production results were the Company’s best quarterly consolidated gold production since the fourth quarter of 2017.” Mr. Duffy continued, “At Costerfield, the excellent results continued from the Youle vein, with the site producing 13,502 gold equivalent ounces. Antimony provided another solid quarter with 933 tonnes sold, the Company’s highest tonnes sold since the second quarter of 2016. The plant pro

ProMIS Neurosciences and BC Neuroimmunology announce revenue-sharing joint venture agreement to develop and offer blood-based diagnostic tests for Alzheimer’s disease9.7.2020 12:30:10 CESTPress release

Testing of blood-based biomarkers will offer convenient detection and monitoring of disease progression in pre-symptomatic and early Alzheimer’s disease (AD) TORONTO and CAMBRIDGE, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a company with unique, core technology to predict novel targets (peptide antigens) on the molecular surface of complex, misfolded proteins, and BC Neuroimmunology Lab (BCNI), have entered into a revenue-sharing joint venture (JV) agreement to develop and offer highly accurate and objective tests for detection, diagnosis and monitoring of Alzheimer’s disease (AD). Significant progress has been made over the past several years to advance a more precise diagnosis of AD. In particular, introduction of the A/T/N (amyloid/tau/neurodegeneration) criteria two years ago offered an unbiased approach for the objective biological diagnosis of AD1. However, the A/T/N diagnostic approach, until recently, required either costly P

Change in board of directors9.7.2020 12:00:00 CESTPress release

Minutes of extraordinary general meeting GG St. Kongensgade 100 & 106 P/S Østergade 1, 1. DK-1100 Copenhagen K CBR no.: 38 30 68 47 On 9 July 2020, an extraordinary general meeting of GG St. Kongensgade 100 & 106 P/S was held at the company’s registered address with the following Agenda: Election of chairman of the extraordinary general meeting Proposed resolution to change the company's board of directors Authorisation Re item 1 on the agenda Jacob Kruse Rasmussen, attorney-at-law, was elected chairman of the extra ordinary general meeting. The chairman of the meeting found that the shareholders had decided to derogate from the requirements in the Danish Companies Act and the articles of association as to form and notice in respect of convening and holding the meeting pursuant to section 76(2) of the Danish Companies Act. On this basis, the chairman of the meeting found that the extra ordinary general meeting formed a quorum in every respect in relation to the items on the agenda. Re

Result of Riksbank reversed auctions SEK Covered Bonds9.7.2020 10:11:23 CESTPress release

Result of Riksbank reversed auctions SEK Covered Bonds Auction date2020-07-09Loan5535 Coupon1.00 %ISIN-codeSE0013358413Maturity2025-09-17 Tendered volume, SEK mln1,000 +/- 500 Volume offered, SEK mln1,250Volume bought, SEK mln1,000Number of bids3Number of accepted bids2Average yield0.249 %Lowest accepted yield0.246 %Highest yield0.251 %% accepted at lowest yield 100.00 Auction date2020-07-09Loan579 Coupon1.00 %ISIN-codeSE0012193621Maturity2024-12-18 Tendered volume, SEK mln1,000 +/- 500 Volume offered, SEK mln2,100Volume bought, SEK mln800Number of bids3Number of accepted bids1Average yield0.165 %Lowest accepted yield0.165 %Highest yield0.165 %% accepted at lowest yield 80.00 Auction date2020-07-09Loan1589 Coupon1.50 %ISIN-codeSE0011643386Maturity2024-12-03 Tendered volume, SEK mln1,000 +/- 500 Volume offered, SEK mln2,400Volume bought, SEK mln1,000Number of bids7Number of accepted bids4Average yield0.169 %Lowest accepted yield0.161 %Highest yield0.176 %% accepted at lowest yield 40.00

Valmet to supply pulp production upgrade technology to PT. Tanjungenim Lestari Pulp and Paper in Indonesia9.7.2020 10:00:00 CESTPress release

Valmet Oyj’s press release on July 9, 2020 at 11:00 a.m. EET Valmet will supply pulp production upgrade technology to PT. Tanjungenim Lestari Pulp and Paper (PT TEL) in Indonesia. The delivery includes an upgrade of continuous cooking system, with a design capacity of 1,800 air dried tonnes per day, and two sets of new automatic baling equipment. With the new investments, PT TEL targets to increase its pulp production capability and improve its pulp quality. The order is included in Valmet's orders received of the second quarter 2020. The value of the order will not be disclosed. An order with this scope of supply and delivery is usually valued in the range of EUR 10-12 million. “Our target in the cooking system upgrade is to reduce our unit wood consumption by increasing the pulp yield and reducing reject content, to enhance our pulp quality and to lower the specific load on the recovery boiler. By upgrading to Valmet’s latest continuous cooking system we will significantly increase t